journal article·2024-10-29

Bone Destruction-Chemotactic Osteoprogenitor Cells Deliver Liposome Nanomedicines for the Treatment of Osteosarcoma and Osteoporosis

Yu Chen, Qi-Wen Chen, Fang-Sheng Fu, Hui-Yun Gu, Aixi Yu, Xian-Zheng Zhang

ACS Nano· Volume 18· Issue 43
Publisher page

Abstract

Therapeutic efficacy of skeletal diseases is usually limited by unfavorable drug delivery due to incapable bone targeting and low bone affinity of conventional drug carriers, as well as relatively reduced vascularization and dense structure of bone tissues. Due to CXC chemokine receptor 4 (CXCR4)/CXC chemokine ligand 12 (CXCL12) signal axis-guided recruitment, osteoprogenitor cells (OPCs) can actively migrate to bone disease nidus. Here, drugs-loaded nanoliposomes are prepared and decorated onto OPCs by biotin-streptavidin linkage for precise bone disease targeting and effective drug delivery. In mouse models of tibia defect and orthotopic osteosarcoma, superior targeting property of OPCs-based drug delivery systems toward diseased bone niduses is verified. By encapsulating antitumor and antiosteoporosis drugs into nanoliposomes, OPCs-based drug delivery systems effectively inhibit disease development and restore bone destruction in mouse models of orthotopic osteosarcoma and ovariectomized osteoporosis. This study reveals a cell-based drug delivery system for precise bone disease targeting and highly effective drug delivery, which will find great potential as a universal drug delivery platform for targeting treatment of various bone diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone health and treatments · Bone Metabolism and Diseases · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Trauma and Microsurgery

Zhongnan Hospital of Wuhan University

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry

Wuhan University

Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering

Central South University

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (40)

Show source-provided references
1. 10.1038/s41571-021-00499-910.1038/s41571-021-00499-9 ↗
2. 10.1126/science.289.5484.150810.1126/science.289.5484.1508 ↗
3. 10.1111/j.1365-2141.1979.tb05862.x10.1111/j.1365-2141.1979.tb05862.x ↗
4. 10.1038/nri313210.1038/nri3132 ↗
5. 10.1016/S2213-8587(17)30188-210.1016/S2213-8587(17)30188-2 ↗
6. 10.1016/j.ejmech.2018.09.02710.1016/j.ejmech.2018.09.027 ↗
7. 10.1126/sciadv.abf205110.1126/sciadv.abf2051 ↗
8. 10.1002/anie.20210193810.1002/anie.202101938 ↗
9. 10.1016/j.cej.2022.13713310.1016/j.cej.2022.137133 ↗
10. 10.1021/acs.nanolett.1c0215010.1021/acs.nanolett.1c02150 ↗
11. 10.1126/sciadv.adf332910.1126/sciadv.adf3329 ↗
12. 10.1126/sciadv.aax694610.1126/sciadv.aax6946 ↗
13. 10.1021/jacs.2c0270610.1021/jacs.2c02706 ↗
14. 10.1517/17425247.2015.102167910.1517/17425247.2015.1021679 ↗
15. 10.1126/scitranslmed.adh975110.1126/scitranslmed.adh9751 ↗
16. 10.1093/hmg/ddn07110.1093/hmg/ddn071 ↗
17. 10.1038/s41565-023-01374-710.1038/s41565-023-01374-7 ↗
18. 10.1038/nri339910.1038/nri3399 ↗
19. 10.1182/blood-2016-03-70033610.1182/blood-2016-03-700336 ↗
20. 10.1126/science.adf649310.1126/science.adf6493 ↗
21. 10.1016/j.biomaterials.2018.06.02610.1016/j.biomaterials.2018.06.026 ↗
22. 10.1038/nrendo.2014.23410.1038/nrendo.2014.234 ↗
23. 10.1016/j.jconrel.2018.12.01910.1016/j.jconrel.2018.12.019 ↗
24. 10.1186/s12951-021-00969-310.1186/s12951-021-00969-3 ↗
25. 10.1016/j.canlet.2015.10.01810.1016/j.canlet.2015.10.018 ↗
26. 10.1126/sciadv.abl805410.1126/sciadv.abl8054 ↗
27. 10.1089/ten.tea.2011.054510.1089/ten.tea.2011.0545 ↗
28. 10.1002/adma.20220329110.1002/adma.202203291 ↗
29. 10.1016/j.biomaterials.2016.08.02310.1016/j.biomaterials.2016.08.023 ↗
30. 10.1126/sciadv.abo616310.1126/sciadv.abo6163 ↗
31. 10.1002/adma.20211009410.1002/adma.202110094 ↗
32. 10.1002/ijc.2432010.1002/ijc.24320 ↗
33. 10.1158/0008-5472.CAN-17-380110.1158/0008-5472.CAN-17-3801 ↗
34. 10.1038/s41467-020-14870-410.1038/s41467-020-14870-4 ↗
35. 10.1126/sciadv.abl643210.1126/sciadv.abl6432 ↗
36. 10.1016/j.nano.2016.01.01010.1016/j.nano.2016.01.010 ↗
37. 10.1016/j.stem.2017.02.00910.1016/j.stem.2017.02.009 ↗
38. 10.1002/advs.20210080810.1002/advs.202100808 ↗
39. 10.1021/jacs.0c0730910.1021/jacs.0c07309 ↗
40. 10.1016/j.biomaterials.2023.12205910.1016/j.biomaterials.2023.122059 ↗